The economic impact of pandemic influenza in the United States: Priorities for intervention

Emerging Infectious Diseases

Volumn 5, Issue 5, 1999, Pages 659-671

  Meltzer, Martin I ^a,b   Cox, Nancy J ^a   Fukuda, Keiji ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ANAPHYLAXIS; ARTICLE; ECONOMIC ASPECT; EPIDEMIC; GUILLAIN BARRE SYNDROME; HEALTH CARE COST; HEALTH CARE POLICY; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MATHEMATICAL MODEL; MORTALITY; OUTPATIENT CARE; UNITED STATES;

EID: 0032741256     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0505.990507     Document Type: Article

References (34)

1. Patriarca PA, Cox NJ. Influenza pandemic preparedness plan for the United States. J Infect Dis 1997;176 Suppl 1:S4-7.
2. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998;178:53-60.
3. Office of Technology Assessment, U.S. Congress. Cost effectiveness of influenza vaccination. Washington: Government Printing Office; 1981.
4. Kavet J. A perspective on the significance of pandemic influenza. Am J Public Health 1977,67:1063-70.
5. Campbell DS, Rumley MA. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med 1997;39:408-14.
6. Carrat F, Valleron A-J. Influenza mortality among the elderly in France, 1980-90: how many deaths may have been avoided through vaccination? J Epidemiol Community Health 1995;49:419-25.
7. Riddiough MA, Sisk JE, Bell JC. Influenza vaccination: cost-effectiveness and public policy. JAMA 1983;249.3189-95.
8. Patriarca PA, Arden NH, Koplan JP, Goodman RA. Prevention and control of type A influenza infections in nursing homes: benefits and costs of four approaches using vaccination and amantadine. Ann Intern Med 1987;107:732-40.
9. Schoenbaum SC. Economic impact of influenza: the individuals perspective. Am J Med 1987;82 Supp 6A:26-30.
10. Jefferson T, Demicheli V. Socioeconomics of influenza. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. London (UK): Blackwell Science; 1998. p. 541-7.
11. Schoenbaum SC, McNeil BJ, Kavet J. The swine-influenza decision. N Eng J Med 1976;295:759-65.
12. Cliff AD, Haggett P. Statistical modelling of measles and influenza outbreaks. Stat Methods Med Res 1993;2:43-73.
13. Critchfield GC, Willard KE. Probabilistic analysis of decision trees using Monte Carlo simulation. Med Decis Making 1986,6:85-92.
14. Dobilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach. Med Decis Making 1985;5:157-77.
15. Dittus RS, Roberts SD, Wilson JR. Quantifying uncertainty in medical decisions. J Am Coll Cardiol 1989;14:23A-8.
16. U S. Bureau of the Census. Statistical abstract of the United States: 1997. 117th ed. Washington: The Bureau; 1997.
17. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1998;47(RR-6):1-26
18. Evans M, Hastings N, Peacock B. Statistical distributions. 2nd ed. New York: John Wiley; 1993.
19. Glezen PW. Emerging infections: pandemic influenza. Epidemiol Rev 1996;18:64-76.
20. Mullooly JP, Barker WH. Impact of type A influenza on children: a retrospective study. Am J Public Health 1982,72:1008-16.
21. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980;112:798-813.
22. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997;87:1944-50.
23. Fox JP, Hall CE, Cooney MK, Foy HM. Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol 1982;116:212-27.
24. Glezen WP, Decker M, Joseph SW, Mercready RG. Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. J Infect Dis 1987;155:1119-26.
25. Serfling RE, Sherman II, Houseworth WJ. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957-58, 1960 and 1963. Am J Epidemiol 1967;86:433-41.
26. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med 1982;142:85-9.
27. Glezen WP, Payne AA, Snyder DN, Downs TD. Mortality and influenza. J Infect Dis 1982,146:313-21.
28. McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med 1993;153:2105-11.
29. Barker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health 1986;76:761-5.
30. Haddix AC, Teutsch SM, Shaffer PA, Dunet DO. Prevention effectiveness. New York: Oxford University Press; 1996.
31. The Federal Register. Vol 61, No 170, 1996 Aug 30; p. 46301-2.
32. Kaufmann AF, Meltzer MI, Schmid GP. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis 1997;3:83-94.
33. Robinson LJ, Barry PJ. The competitive firm's response to risk. New York: Macmillian; 1987.
34. Neustadt RE, Fineberg HV. The swine flu affair: decision making on a slippery disease. Washington: U.S. Department of Health Education, and Welfare; 1978.